Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 432 | 24 | 5.6 | 123 | 28.5 | 170 | 39.4 | 67 | 15.5 | 48 | 11.1 |
2015-2019 | 416 | 20 | 4.8 | 131 | 31.5 | 151 | 36.3 | 57 | 13.7 | 57 | 13.7 |
2014-2018 | 393 | 19 | 4.8 | 130 | 33.1 | 136 | 34.6 | 54 | 13.7 | 54 | 13.7 |
2013-2017 | 391 | 18 | 4.6 | 125 | 32.0 | 130 | 33.2 | 56 | 14.3 | 62 | 15.9 |
2012-2016 | 358 | 12 | 3.4 | 120 | 33.5 | 121 | 33.8 | 54 | 15.1 | 51 | 14.2 |
2011-2015 | 358 | 8 | 2.2 | 132 | 36.9 | 109 | 30.4 | 65 | 18.2 | 44 | 12.3 |
2010-2014 | 366 | 14 | 3.8 | 129 | 35.2 | 111 | 30.3 | 75 | 20.5 | 37 | 10.1 |
2009-2013 | 370 | 13 | 3.5 | 136 | 36.8 | 108 | 29.2 | 76 | 20.5 | 37 | 10.0 |
2008-2012 | 410 | 20 | 4.9 | 157 | 38.3 | 116 | 28.3 | 82 | 20.0 | 35 | 8.5 |
2007-2011 | 428 | 28 | 6.5 | 152 | 35.5 | 119 | 27.8 | 86 | 20.1 | 43 | 10.0 |
2006-2010 | 446 | 35 | 7.8 | 142 | 31.8 | 143 | 32.1 | 76 | 17.0 | 50 | 11.2 |
2005-2009 | 474 | 48 | 10.1 | 153 | 32.3 | 143 | 30.2 | 69 | 14.6 | 61 | 12.9 |
2004-2008 | 488 | 51 | 10.5 | 151 | 30.9 | 151 | 30.9 | 62 | 12.7 | 73 | 15.0 |
2003-2007 | 475 | 52 | 10.9 | 150 | 31.6 | 141 | 29.7 | 53 | 11.2 | 79 | 16.6 |
2002-2006 | 481 | 52 | 10.8 | 158 | 32.8 | 141 | 29.3 | 46 | 9.6 | 84 | 17.5 |
2001-2005 | 501 | 50 | 10.0 | 182 | 36.3 | 130 | 25.9 | 49 | 9.8 | 90 | 18.0 |
2000-2004 | 490 | 37 | 7.6 | 179 | 36.5 | 143 | 29.2 | 51 | 10.4 | 80 | 16.3 |
1999-2003 | 501 | 35 | 7.0 | 181 | 36.1 | 159 | 31.7 | 56 | 11.2 | 70 | 14.0 |
1998-2002 | 522 | 31 | 5.9 | 170 | 32.6 | 183 | 35.1 | 66 | 12.6 | 72 | 13.8 |
1997-2001 | 506 | 24 | 4.7 | 161 | 31.8 | 189 | 37.4 | 68 | 13.4 | 64 | 12.6 |
1996-2000 | 460 | 21 | 4.6 | 139 | 30.2 | 180 | 39.1 | 64 | 13.9 | 56 | 12.2 |
1995-1999 | 434 | 16 | 3.7 | 132 | 30.4 | 167 | 38.5 | 64 | 14.7 | 55 | 12.7 |
1994-1998 | 428 | 13 | 3.0 | 137 | 32.0 | 162 | 37.9 | 63 | 14.7 | 53 | 12.4 |
1993-1997 | 413 | 11 | 2.7 | 154 | 37.3 | 141 | 34.1 | 58 | 14.0 | 49 | 11.9 |
1992-1996 | 437 | 13 | 3.0 | 159 | 36.4 | 152 | 34.8 | 58 | 13.3 | 55 | 12.6 |
1991-1995 | 457 | 15 | 3.3 | 166 | 36.3 | 156 | 34.1 | 65 | 14.2 | 55 | 12.0 |
1990-1994 | 477 | 17 | 3.6 | 161 | 33.8 | 157 | 32.9 | 68 | 14.3 | 74 | 15.5 |
1989-1993 | 467 | 20 | 4.3 | 146 | 31.3 | 137 | 29.3 | 69 | 14.8 | 95 | 20.3 |
1988-1992 | 465 | 25 | 5.4 | 118 | 25.4 | 142 | 30.5 | 69 | 14.8 | 111 | 23.9 |
1987-1991 | 448 | 25 | 5.6 | 108 | 24.1 | 127 | 28.3 | 68 | 15.2 | 120 | 26.8 |
1986-1990 | 420 | 21 | 5.0 | 99 | 23.6 | 114 | 27.1 | 62 | 14.8 | 124 | 29.5 |
1985-1989 | 421 | 20 | 4.8 | 106 | 25.2 | 123 | 29.2 | 66 | 15.7 | 106 | 25.2 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |